We previously reported that IgE antibodies specific for melanoma and ovarian cancer antigens stimulate pro-inflammatory activation of immune effector cells,15 16 however, this has not yet been evaluated with anti-HER2 IgEs or in the breast cancer context. This evidence concerns the gene ERBB2 and ovarian cancer.